A BMJ review of 37 studies found weight returns within about two years, and faster after medication than after behavioral programs.
SAN FRANCISCO, CA, UNITED STATES, October 9, 2026 /EINPresswire.com/ — The moment a patient stops taking a GLP-1 medication, the mental chatter about food often comes roaring back, and new research suggests the scale follows. A January analysis in The BMJ, which pooled data from 37 separate studies, found that participants shed roughly a pound each month and typically landed back at their original weight within about two years of stopping treatment.
Notably, the same review found that weight regained more quickly after discontinuing medication than it did after behavioral weight management programs, regardless of how much weight the person had initially lost. This highlights a growing concern for the millions of Americans cycling off these drugs without a clear plan for what comes next.
Sandy Zeldes, a Certified Nutrition Consultant and Advanced EFT Practitioner who has spent over two decades helping people navigate cravings and emotional eating, says these findings mirror what she has witnessed firsthand since GLP-1s became a mainstream treatment.
“The medication turned the volume down. It never answered the question,” Zeldes said. “So when the volume comes back up, people assume they have failed at something. They haven’t. Nothing was ever resolved. It was quieted.”
The phenomenon known as “food noise”—the persistent, intrusive thoughts about eating—has now become a measurable metric in clinical research. At this year’s European Congress on Obesity, scientists from Pennington Biomedical Research Center unveiled findings using a validated Food Noise Questionnaire, providing the first empirical evidence that GLP-1 medications suppress food noise more effectively than behavioral interventions alone.
For Zeldes, that scientific validation doesn’t contradict her approach; it reinforces it.
“The drugs do exactly what they say. That is not in question,” she said. “The question is what happens in the 18 months after somebody stops, and right now the honest answer is that most people are not prepared for it.”
A 2026 analysis tracking individuals who discontinued GLP-1 treatment paints a stark picture of that lack of preparation. Only 14% of those patients adopted structured lifestyle changes to maintain their progress. Meanwhile, more than a quarter switched to a different weight loss medication, and nearly one in five restarted their original prescription within roughly six months of stopping.
Zeldes notes that by the time clients reach her, they have typically exhausted a long checklist of conventional solutions.
“They tell me they have done therapy, diets, cleanses, nutritionists, functional medicine, the medication, sometimes surgery, and they still cannot control the wanting,” she said. “Every one of those approaches was aimed at hunger. This was never really about hunger.”
She argues that the root of the problem usually has little to do with food itself.
“The wanting is doing something. It is regulating something, or soothing something, or standing in for something,” Zeldes said. “Until you know what, you are managing a symptom.”
Her perspective is backed by a June study from Stanford Medicine, in which patients themselves pushed back against the idea that GLP-1s function as a cure. Instead, they described the medications as tools that cleared space for change—without creating the change on their own.
“That is the most useful sentence anyone has written about these drugs,” Zeldes said. “The room is real. What people do with it is the part nobody is helping them with.”
Zeldes brings an unusual background to her practice, having trained as a professional chef before earning her Certified Nutrition Consultant credential through Bauman College. She studied Emotional Freedom Techniques directly with its founder, Gary Craig, and is listed in EFT practitioner directories. Her client work focuses on the underlying patterns that drive cravings, steering clear of restriction-based dieting or rigid meal planning.
You can learn more at sandyzeldes.com
Sandy Zeldes
Sandy Zeldes
hello@sandyzeldes.com
Visit us on social media:
LinkedIn
Instagram
YouTube
X
Why it matters: As millions of patients confront the reality of weight regain after stopping GLP-1s, the conversation is shifting from short-term efficacy to long-term sustainability. This story underscores the urgent need for integrated support systems that address the emotional and psychological drivers of food noise, not just the biological ones.
